These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 6177959

  • 21. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R, Hilliquin P.
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [Abstract] [Full Text] [Related]

  • 22. [Changes in serum lipid levels, lipid composition and lipoprotein fractions in patients with ischemic cardiopathies or arterial hypertension].
    Dakovska L, Orbetzov M, Orbetzova V, Yarovska N.
    Paroi Arterielle; 1981 Jan; 7(1):15-22. PubMed ID: 7339537
    [Abstract] [Full Text] [Related]

  • 23. [Antihypertensive therapy and lipid metabolism].
    Krone W, Müller-Wieland D, Greten H.
    Klin Wochenschr; 1984 Mar 01; 62(5):193-202. PubMed ID: 6143851
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW, Petrasovits A, Stachenko S, MacLean DR, Little JA, Chockalingam A.
    Can J Cardiol; 1999 Apr 01; 15(4):428-33. PubMed ID: 10322252
    [Abstract] [Full Text] [Related]

  • 25. Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status.
    Holtzman E, Rosenthal T, Goldbourt U, Segal P.
    Isr J Med Sci; 1984 Dec 01; 20(12):1169-76. PubMed ID: 6519949
    [Abstract] [Full Text] [Related]

  • 26. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS, Kashyap ML.
    Pharmacotherapy; 2004 Dec 01; 24(12):1692-713. PubMed ID: 15585439
    [Abstract] [Full Text] [Related]

  • 27. The influence of exercise on the concentrations of triglyceride and cholesterol in human plasma.
    Haskell WL.
    Exerc Sport Sci Rev; 1984 Dec 01; 12():205-44. PubMed ID: 6376133
    [Abstract] [Full Text] [Related]

  • 28. Relationship of lipid disorders to coronary heart disease.
    Glueck CJ.
    Am J Med; 1983 May 23; 74(5A):10-4. PubMed ID: 6846376
    [Abstract] [Full Text] [Related]

  • 29. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J.
    Can J Cardiol; 1997 Mar 23; 13(3):253-60. PubMed ID: 9117913
    [Abstract] [Full Text] [Related]

  • 30. [Adrenergic mechanisms and their significance for plasma lipid concentrations].
    Day JL.
    Wien Med Wochenschr; 1982 Mar 23; 132 Spec No 2():19-22. PubMed ID: 6132497
    [No Abstract] [Full Text] [Related]

  • 31. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP, Pépin GM, Mahley RW.
    Am Heart J; 2003 Dec 23; 146(6):1052-9. PubMed ID: 14660998
    [Abstract] [Full Text] [Related]

  • 32. The effect on HDL cholesterol of oxprenolol and atenolol.
    Kjeldsen SE, Eide I, Leren P, Foss OP, Holme I, Eriksen IL.
    Scand J Clin Lab Invest; 1982 Sep 23; 42(5):449-53. PubMed ID: 6130595
    [Abstract] [Full Text] [Related]

  • 33. Alterations in plasma lipids consequent to endurance training and beta-blockade.
    Morton AR, Stanforth PR, Freund BJ, Joyner MJ, Jilka SM, Hartzell AA, Ewy GA, Wilmore JH.
    Med Sci Sports Exerc; 1989 Jun 23; 21(3):288-92. PubMed ID: 2567483
    [Abstract] [Full Text] [Related]

  • 34. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun 23; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 35. Effect of antihypertensive agents on lipid metabolism.
    Cutler R.
    Am J Cardiol; 1983 Feb 24; 51(4):628-31. PubMed ID: 6131603
    [Abstract] [Full Text] [Related]

  • 36. The biochemical effects of antihypertensive agents and the impact on atherosclerosis.
    Lowenstein J, Neusy AJ.
    J Cardiovasc Pharmacol; 1982 Feb 24; 4 Suppl 2():S262-4. PubMed ID: 6177970
    [No Abstract] [Full Text] [Related]

  • 37. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA.
    J Ren Nutr; 2009 Jan 24; 19(1):73-7. PubMed ID: 19121776
    [Abstract] [Full Text] [Related]

  • 38. Beta-blockers, plasma lipids, and coronary heart disease.
    Cruickshank JM.
    Circulation; 1990 Sep 24; 82(3 Suppl):II60-5. PubMed ID: 1975524
    [Abstract] [Full Text] [Related]

  • 39. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW, Stachenko S, MacLean DR, Petrasovits A, Little JA.
    Can J Cardiol; 1999 Apr 24; 15(4):419-27. PubMed ID: 10322251
    [Abstract] [Full Text] [Related]

  • 40. Epidemiological and cost implications of antihypertensive treatment for the prevention of cardiovascular disease.
    Grimm RH.
    J Hum Hypertens; 1989 Dec 24; 3 Suppl 2():55-60; discussion 60-1. PubMed ID: 2514265
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.